Guang Yang
Blueprint Medicines (United States)
ORCID: 0000-0003-3049-4200Also affiliated with Dana-Farber Cancer Institute
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 12 papers. Top paper: “Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia”.
Kirsten Meid, Joshua Gustine, Carly Leventoff, Timothy P. White, Catherine Flynn +17 more
Kirsten Meid, Zachary R. Hunter, Catherine Flynn, Shayna Sarosiek, Carly Leventoff +17 more
SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas
Xia Liu, Jiaji G. Chen, Lian Xu, Nickolas Tsakmaklis, Maria Demos +19 more
Jorge J. Castillo, Alan P Skarbnik, Jacob D. Soumerai, Irene M. Ghobrial, Maria Luisa Guerrera +3 more
Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides +17 more
Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter +18 more
Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Zachary R. Hunter, Maria Luisa Guerrera +15 more
Zachary R. Hunter, Lian Xu, Nicholas Tsakmaklis, Amanda Kofides, Manit Munshi +14 more
Guang Yang, Li Wang, Scott B. Ficarro, Sara J. Buhrlage, Hao Wu +4 more
Xia Liu, Choudhury Fabliha B. Yusuf, Amanda Kofides, Kara M. Soroko, Johany Peñailillo +17 more
Gloria Chan, Lian Xu, Nickolas Tsakmaklis, Amanda Kofides, Maria Demos +10 more
Jiaji G. Chen, Manit Munshi, Zachary R. Hunter, Lian Xu, Amanda Kofides +12 more